This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Peter Nower
Introduction
Peter Nower is a notable inventor based in Wethersfield, CT (US). He has made significant contributions to the field of medical research, particularly in the development of assays for the Hepatitis C virus. His work has implications for both the identification of inhibitors and the treatment of this viral infection.
Latest Patents
Peter Nower holds 1 patent related to Hepatitis C virus assays. This invention includes an assay that is useful for identifying inhibitors of Hepatitis C virus (HCV) activity. The dual HCV assay is designed for high throughput screening, quantifying both the amount of HCV RNA replication inhibitory activity associated with a test compound and the cytotoxicity of that compound. Additionally, the invention encompasses compounds discovered using this assay, compositions containing such compounds, and methods for treating Hepatitis C through the administration of these compounds. The patent also includes reporter assays utilizing enzymes associated with HCV RNA replication, as well as a specific cell line with ATTC Accession No. PTA-4583.
Career Highlights
Peter Nower is affiliated with Bristol-Myers Squibb Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of Hepatitis C, showcasing his commitment to medical innovation.
Collaborations
Peter has collaborated with notable colleagues, including Donald R O'Boyle and Min Gao. These partnerships have enhanced the research efforts and outcomes in their shared field of study.
Conclusion
Peter Nower's innovative work in developing assays for Hepatitis C virus demonstrates his significant impact on medical research. His contributions continue to pave the way for advancements in the treatment of viral infections.